Terminated PHASE1 INTERVENTIONAL 1-arm NCT05457491

Novel Antiaging Regenerative Skin Care Regimen Containing Human Platelet Extract (HPE)

Sponsor: Mayo Clinic

Interventions EltaMD PM Therapy Facial Moisturizer EltaMD UV Daily Broad-Spectrum SPF 40 Human platelet extract (cosmetic product) Vanicream Gentle Facial Cleanser Vanicream Lite Lotion

Updated 4 times since 2022 Last updated: Sep 24, 2024 Started: Oct 1, 2021 Primary completion: Jul 7, 2022 Completion: Jul 7, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Principal Investigator discretion

Other terminated trials from Mayo Clinic

See all terminations from Mayo Clinic

Listed as NCT05457491, this PHASE1 trial focuses on Skin Aging and remains terminated or withdrawn. Sponsored by Mayo Clinic, it has been updated 4 times since 2021, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

4 versions recorded

Nov 2024 — Present [monthly]

Terminated PHASE1

Status: Completed → Terminated
Sep 2024 — Nov 2024 [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Sep 2022 — Jul 2024 [monthly]

Completed PHASE1

First recorded

Oct 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Mayo Clinic

Data source: Mayo Clinic

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Rochester, United States